Michael J. Fox Foundation for Parkinson’s Research: Multiple opportunities – Pre-proposals

Target Advancement: Target validation (1 yr, $100K), Target optimization (2 yrs, $400K), Priority targets - alpha-synuclein, LRRK2, GBA, parkin and trophic factors (1 yr, $100K).
Therapeutic Pipeline Program: Disease-modifying or symptomatic strategies, either at pre-clinical or clinical stages No set budget limit-2 yrs.
Outcome Measures: Imaging agents, biomarkers, clinical outcomes. No set budget.
https://www.michaeljfox.org/research/apply-for-grant.html